# FDA recall D-573-2013

> **Novartis Consumer Health** · Class III · drug recall initiated 2013-02-19.

## Product

Novartis Lamisil AT Cream, Terbinafine Hydrochloride Cream 1% Antifungal,  Novartis Consumer Health, Inc., Parsippany, NJ.     (a)12 gm (.42 oz), packaged with UPC code 300673998421 and NDC code: 0067-3998-42;   (b) 12 gm  (.42 oz), packaged with UPC code:  300673998124 and NDC code: 0067-3998-12;  (c) 30 gm  (1 oz), packaged with UPC code:  300673998308 and NDC code: 0067-3998-30;  (d) 30 gm  (1 oz), packaged with UPC code:  300673998339 and NDC code: 0067-3998-33.

## Reason for recall

Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot.

## Distribution

Nationwide and Puerto Rico, and Panama.  Military distribution made.

## Key facts

- **Recall number:** D-573-2013
- **Recalling firm:** Novartis Consumer Health
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-02-19
- **Report date:** 2013-06-12
- **Termination date:** 2014-11-26

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Lincoln, NE, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-573-2013

## Citation

> AI Analytics. FDA recall D-573-2013. Retrieved 2026-05-27 from https://api.ai-analytics.org/recall/D-573-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*